1. Articles in category: Other Business News

    1-24 of 1233 1 2 3 4 ... 50 51 52 »
    1. Introducing the Santec OPS-1000 3D Optical Profiler

      Introducing the Santec OPS-1000 3D Optical Profiler

      Santec introduces the new 3D Optical Profiler, OPS-1000. Designed to support R&D and production environments the OPS-1000 delivers fast, accurate and wide 3D object scans with high sensitivity, capturing surfaces other profilers may miss. A wide system dynamic range of >70dB enables non-contact, high-speed measurements with high accuracy, regardless of shape, material, color or surface condition. Intuitive control software allows the user to quickly configure scan profiles, automate testing, and export the point cloud data for analysis.

      Read Full Article
      Mentions: Santec
    2. HP-OCT™ wins Victorian AEEA award – nominated for Sir William Hudson award

      HP-OCT™ wins Victorian AEEA award – nominated for Sir William Hudson award

      Cylite Pty Ltd, a developer and manufacturer of 4 th Generation OCT systems for Ophthalmology and Optometry, is thrilled to announce it has won the Australian Engineering Excellence Award Victoria. The Australian Engineering Excellent Awards first began in 1988, after a decade of celebrating local projects through an Engineers Australia office. Brought to the national stage, an excellence award recognises outstanding achievement in engineering and the invaluable contribution that engineering makes to the economy, community and environment. Winning projects exhibit excellence, distinction, merit, perfection and quality. Kylee Hall, Cylite’s VP Sales and Marketing Manager commented, ”It is such an ...

      Read Full Article
      Mentions: Cylite
    3. Avinger Receives FDA Clearance of Ocelaris Next Generation Image-guided CTO Crossing System

      Avinger Receives FDA Clearance of Ocelaris Next Generation Image-guided CTO Crossing System

      Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today announced that the Company received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its Ocelaris next generation image-guided chronic total occlusion (CTO) crossing system. The new device will be marketed under the brand name TIGEREYE™ to reinforce its highly differentiated benefit of providing real-time imaging from inside the vessel during a CTO-crossing procedure. TIGEREYE is a product line extension of Avinger's Ocelot family of image-guided ...

      Read Full Article
      Mentions: FDA Avinger
    4. PhotoniCare Announces More Than $7 Million in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology

      PhotoniCare Announces More Than $7 Million in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology

      PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools, today announced an oversubscribed $5.2 million Series A financing led by i2E Management Company Inc., with co-investment from OSF Ventures, Sony Innovation Fund, and Dreampact Ventures. The company also announced that it has received a $2.1 million Phase II Small Business Innovation Research ( SBIR ) grant from the National Institutes of Health ( NIH ). The competitive NIH SBIR program funds early-stage small businesses seeking to commercialize innovative biomedical technologies. In January, PhotoniCare announced that the U.S. Food and Drug Administration (FDA) had granted clearance ...

      Read Full Article
    5. AI-based OCT analysis of AREDS2 10-Y follow-on study demonstrates superior performance over retina specialists

      AI-based OCT analysis of AREDS2 10-Y follow-on study demonstrates superior performance over retina specialists

      Data analysis from Age-Related Eye Disease Study 2 10-year Follow-On Study (AREDS2-10Y) participants shows that the Notal Optical Coherence Tomography (OCT) Analyzer, which uses machine learning and image recognition computational techniques to identify, quantify and map intra- and subretinal fluid in wet age-related macular degeneration (AMD), achieved a higher level of accuracy than that of retina specialists, who had imperfect accuracy and low sensitivity in detecting retinal fluid. The study, recently published in Opthalmology, was presented at the American Society of Retina Specialist virtual annual meeting on July 24, 2020. “The study results show how challenging it is to identify ...

      Read Full Article
      Mentions: FDA Notal Vision
    6. HP-OCT™ from Cylite receives Australian Made certification

      HP-OCT™ from Cylite receives Australian Made certification

      Cylite Pty Ltd, a developer and manufacturer of 4 th Generation OCT systems for Ophthalmology and Optometry, is pleased to announce that it has been awarded Australian Made status. The Australian Made, Australian Grown logo is administered by Australian Made Campaign Limited (AMCL), a not-for-profit public company established in 1999 by the Australian Chamber of Commerce & Industry (ACCI) and the network of state and territory chambers of commerce, with the cooperation of the Federal Government. In 2002, the Federal Government transferred ownership of the logo to AMCL via a Deed of Assignment and Management, which sets out strict conditions under ...

      Read Full Article
      Mentions: Cylite
    7. Home OCT with AI analysis may lead to ‘paradigm shift’ in AMD management

      Home OCT with AI analysis may lead to ‘paradigm shift’ in AMD management

      A novel artificial intelligence-based algorithm for automatic retinal fluid quantification in home OCT images performed comparably to human readers, according to a presentation from the virtual American Society of Retina Specialists meeting. This system was able to analyze fluid status, its dynamics and visualize the locations of fluid, Judy E. Kim, MD, professor of ophthalmology and visual sciences at Medical College of Wisconsin, said during the presentation. “Currently, much of our diagnosis and management of eyes with exudative AMD is dependent on OCT. At-home diagnostic testing systems, such as home OCT, offer an opportunity for personalizing AMD management by providing ...

      Read Full Article
      Mentions: Notal Vision
    8. Rowe Technical Design, Inc. announces their newest tissue phantom/Model Eye for OCT is now in production!

      Rowe Technical Design, Inc. announces their newest tissue phantom/Model Eye for OCT is now in production!

      Rowe Technical Design (RTD), developers of the broadest selection of optical tissue phantoms for OCT and fundus imaging has announced that their latest version of the Cornea tissue phantom for OCT has now been released for full serial production. “We’re excited because this is our fifth serial production model eye, following up on the very successful anterior chamber model eye” notes T. Scott Rowe, company founder and president. “We are extremely pleased with the customer feedback so far, ready for successful volume manufacturing. The Cornea model eye incorporates an 11.0 mm diameter cornea with 470 um central corneal ...

      Read Full Article
      Mentions: T. Scott Rowe
    9. New Cobra 1600 OCT spectrometer from Wasatch Photonics

      New Cobra 1600 OCT spectrometer from Wasatch Photonics

      Wasatch Photonics, Inc. has expanded its Cobra OCT spectrometer product line with a new 1600 nm OCT spectrometer for deep-tissue, SD-OCT imaging. The Cobra 1600 builds on the company’s existing line of more than 25 off-the-shelf OCT spectrometer models at visible, 800 nm, 1050 nm, and 1300 nm wavelengths, with camera speeds up to 250 kHz. Addition of a 1600 nm model offers greater depth penetration with high contrast for highly scattering tissues and materials, with applications in cardiology, neurology, dermatology, dentistry, and non-destructive testing. The Cobra 1600 OCT spectrometer utilizes a 240 nm bandwidth centered at 1570 nm ...

      Read Full Article
    10. Santec announces sales launch by Alcon of SS-OCT biometer for cataract specialists in Japan under the brand MOVU

      Santec announces sales launch by Alcon of SS-OCT biometer for cataract specialists in Japan under the brand MOVU

      Santec Corporation, a leading manufacturer of advanced optical components, tunable lasers, optical test equipment and OCT systems, today announced the sales launch, through Alcon Japan, of the Swept Source Optical Coherence Tomography (SS-OCT) biometer ARGOS ® (model name: ARGOS ® ver1.5.). The ARGOS ® , sold under the brand MOVU ® , incorporates Santec’s market leading SS-OCT technology and is used to measure key parameters of the eye, including axial length, prior to cataract surgery. "ARGOS ® Ver.1.5" integrates the biometric and surgical planning functions of the cataract surgery guide system “VERION™” and will be released in Japan on August 3, 2020. “VERION ...

      Read Full Article
      Mentions: Santec FDA Alcon
    11. Kubota Vision Demonstrates 3D Imaging Capabilities Using AI on PBOS

      Kubota Vision Demonstrates 3D Imaging Capabilities Using AI on PBOS

      Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company demonstrated 3D imaging capabilities using artificial intelligence (AI) on our Patient Based Ophthalmology Suite (PBOS), in-home optical coherence tomography (OCT) device.*1 Kubota Vision completed a successful clinical study in October 2018 that demonstrated the PBOS could detect thinning and thickening of the human retina over time, when compared to results from an established commercial OCT device. (See October 28, 2018 press release titled “Acucela Completes PBOS Clinical Study and Validates Concept.”) A commercial OCT ...

      Read Full Article
      Mentions: Acucela Kubota
    12. Perimeter Medical Imaging AI, Inc. Announces Stock Exchange Listing (TSX.V: PINK); Closing of Oversubscribed C$10m Private Placement Financing; Completion of Plan of Arrangement with New World

      Perimeter Medical Imaging AI, Inc. Announces Stock Exchange Listing (TSX.V: PINK); Closing of Oversubscribed C$10m Private Placement Financing; Completion of Plan of Arrangement with New World

      Medical imaging and AI company Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") announced that the previously announced reverse take-over of New World Resource Corp. (" New World ") by Perimeter Medical Imaging, Inc. (" Pre-Closing Perimeter ") via plan of arrangement (the " Plan of Arrangement ") has been completed. As a result, Perimeter will be listed as a Tier 2 issuer on the TSX-V. Immediately following closing of the Plan of Arrangement, Perimeter, the resulting issuer following the Plan of Arrangement, closed its previously announced non-brokered private placement financing (the " Offering ") of units (" Units ") on an oversubscribed basis for gross proceeds of C ...

      Read Full Article
    13. Wasatch Photonics adds 1600 nm OCT spectrometer for deep tissue imaging

      Wasatch Photonics adds 1600 nm OCT spectrometer for deep tissue imaging

      Wasatch Photonics has expanded its Cobra OCT spectrometer product line with a new 1600 nm OCT spectrometer for deep-tissue, SD-OCT imaging. The Cobra 1600 builds on the company’s existing line of more than 25 off-the-shelf OCT spectrometer models at visible, 800 nm, 1050 nm, and 1300 nm wavelengths, with camera speeds up to 250 kHz. Addition of a 1600 nm model offers greater depth penetration with high contrast for highly scattering tissues and materials, with applications in cardiology, neurology, dermatology, dentistry, and non-destructive testing. The Cobra 1600 OCT spectrometer utilizes a 240 nm bandwidth centered at 1570 nm to ...

      Read Full Article
    14. The Next Innovation in PCI Is Not a Stent: The Value of Optical Coherence Tomography (OCT)

      The Next Innovation in PCI Is Not a Stent: The Value of Optical Coherence Tomography (OCT)

      For decades, percutaneous coronary intervention (PCI) has largely been guided solely by angiography, despite its well-documented limitations. 1 Angiography offers a two-dimensional view of a three-dimensional structure and does very little to delineate the composition of the coronary artery. Additionally, angiography poorly quantitates the severity and location of calcium, does not provide information about plaque morphology, nor does it provide highly accurate and reproducible lumen sizing. For PCI, the operator is limited by angiography in identifying stent malapposition or under-expansion, edge dissections, or plaque protrusion. In short, we have not been seeing the full story. By providing the highest resolution ...

      Read Full Article
      Mentions: Abbot
    15. New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages

      New Research Finds Abbott's Optical Coherence Tomography Imaging Changed Treatment Decisions in 88% of Artery Blockages

      Abbott (NYSE: ABT ) today announced new data from the company's LightLab Initiative that showed optical coherence tomography (OCT) imaging significantly changes how physicians decide to treat a vessel compared to traditional angiography by providing physicians improved visualization within a patient's blood vessels. Data from the study revealed physicians altered their treatment strategy in 88% of coronary artery blockages based on new information provided by OCT. Using laser technology, OCT captures high-resolution images inside a patient's arteries, displaying the type and severity of disease in the vessel, as well as enabling more accurate measurements to determine how the ...

      Read Full Article
    16. Aqua Licensing LLC Retained to Explore the Sale of of the Compact Imaging OCT Patent Portfolio

      Aqua Licensing LLC Retained to Explore the Sale of of the Compact Imaging OCT Patent Portfolio

      Aqua Licensing LLC has been retained to explore the sale of of the Compact Imaging OCT patent portfolio. This patent portfolio is developed, owned and offered for sale by Compact Imaging, Inc., the developers of MRO™ (multiple reference OCT) technology. The portfolio anticipated the development of features that are now market standard in Optical Coherence Tomography (“OCT”) and Fundus imaging devices and applications. These features are deployed industry-wide in ophthalmology and have become the clinical standard of care in ophthalmic diagnostic imaging. Claim charts are available under NDA that illustrate the reads on products with covered revenue in excess of ...

      Read Full Article
    17. Home OCT longitudinal home-based study with patient self-operated device has begun

      Home OCT longitudinal home-based study with patient self-operated device has begun

      Notal Vision is proud to announce the enrollment of patients in the first longitudinal home-based study with its investigational home optical coherence tomography (OCT) remote monitoring device. The study will explore the daily dynamics of retinal fluid in patients receiving anti-VEGF treatment for wet age-related macular degeneration (AMD). The Home OCT System pipeline technology is designed to provide home-based, patient-initiated retinal OCT scans to support the management of patients with wet AMD, complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. “The study is an important milestone for our Home OCT pipeline ...

      Read Full Article
    18. LighTopTech Corp. Receives Small Business Innovation Research Phase II Award from the US National Institutes of Health (NIH)

      LighTopTech Corp. Receives Small Business Innovation Research Phase II Award from the US National Institutes of Health (NIH)

      LighTopTech Corp., an upstate New York-based company building innovative optical instruments to bring to market disruptive imaging technologies industrial and medical fields, has been awarded a Phase II Small Business Innovation Research (SBIR) award by the National Eye Institute of the National Institutes of Health (NIH). The NIH Phase II award will allow LighTopTech to develop the first 3D high-definition imaging instrument based on Gabor-Domain Optical Coherence Microscopy (GDOCM) for quantitative assessment of corneal tissue at eye banks. LighTopTech will develop and apply machine learning methods to automatically segment the endothelial cells of the cornea and count them to assess ...

      Read Full Article
    19. Perimeter Medical Imaging Receives $7.44 Million CPRIT Grant To Further Develop AI ImgAssist Technology at Leading Cancer Centers in Texas

      Perimeter Medical Imaging Receives $7.44 Million CPRIT Grant To Further Develop AI ImgAssist Technology at Leading Cancer Centers in Texas

      Perimeter Medical Imaging , a medical device company, today announces that it has received a $7.44 million grant from CPRIT, a leading state body funding cancer research, to continue developing its artificial intelligence technology that can help surgeons identify if cancer is still present post-tumor removal surgery. The sponsored technology, known as OTIS™, is designed to provide real-time information during breast cancer surgery. The platform’s ability to deliver ultra-high resolution and sub-surface image volumes across the surface of the removed tissue allows surgeons to assess if they have achieved the successful removal of the entire tumor. Should a surgeon ...

      Read Full Article
    20. Eye in the Sky: Video Game to Improve the Automation of Interpreting OCT Scans for the diagnosis and treatment of AMD

      Eye in the Sky: Video Game to Improve the Automation of Interpreting OCT Scans for the diagnosis and treatment of AMD

      Optical coherence tomography (OCT) scans can be used to diagnose and evaluate the effectiveness of various treatments and therapies for patients with Age-Related Macular Degeneration (AMD), the leading cause of severe visual impairment in the developed world. While there are treatments for some forms of wet AMD there is nothing to help the vast majority of patients suffering from the dry or degenerative form of AMD. One of the major obstacles in the development of an effective treatment is the inability to detect objective criteria that would either herald further progression of the disease or identify aspects that suggest improvement ...

      Read Full Article
    21. Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance

      Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance

      Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, today announced revenue of $243.5 million for the quarter ended March 31, 2020, an increase of 2.2% over revenue of $238.3 million for the quarter ended March 31, 2019....$1.4M Represents write-off of inventory related to our distribution agreement with NinePoint Medical, Inc.

      Read Full Article
    22. ZEISS Medical Technology Announces Changes in Ophthalmic Devices Executive Leadership

      ZEISS Medical Technology Announces Changes in Ophthalmic Devices Executive Leadership

      Effective 1 May 2020, Jim Mazzo will retire from his position as President Ophthalmic Devices and Head of the Ophthalmic Devices Strategic Business Unit for ZEISS. He will continue to support ZEISS as an advisor. With over forty years in the ophthalmic industry, Jim has successfully transformed ZEISS Global Ophthalmic Devices as the number two industry leader in Ophthalmology by creating a strong customer focused organization within his three plus years with ZEISS. "I am very proud of what we have accomplished for customers and employees and pleased to hand over responsibility to Euan and the team. With this team ...

      Read Full Article
    23. Cylite receives ISO 13485 Certification

      Cylite receives ISO 13485 Certification

      Cylite Pty Ltd, a developer and manufacturer of 4 th Generation OCT systems for Ophthalmology and Optometry, is pleased to announce that it has been awarded International Organization for Standardization (ISO) 13485:2016 certification for medical device quality management systems (QMS) following review by BSI. ISO 13485:2016 is an internationally recognized quality standard specific to the medical device industry. ISO 13485 certification affirms to Cylite’s patients and partners that the company is providing the best quality management systems and regulatory compliance for its 4 th generation OCT platform. Yameena Ratnayake, Cylite’s Quality Manager commented,” We are very ...

      Read Full Article
      Mentions: Cylite
    1-24 of 1233 1 2 3 4 ... 50 51 52 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (2 articles) FDA
    2. (1 articles) National Institutes of Health
  4. People in the News

    1. (1 articles) Ryan L. Shelton
  5. OCT Companies in the News

    1. (1 articles) Cylite
    2. (1 articles) Santec
    3. (1 articles) Avinger
    4. (1 articles) PhotoniCare